Skip to content

Drug interactions

Ifosfamide + Tazemetostat

Severity: Minor

Ifosfamide and Tazemetostat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tazemetostat is a weak CYP3A4 inducer and a CYP3A4 substrate, and ifosfamide is a substrate with possible weak inhibitory effects. Any change in exposure is probably small, but ifosfamide activation could change slightly.

What this interaction means in plain words

Ifosfamide and Tazemetostat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ifosfamide belongs to Oncology; Tazemetostat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by tazemetostat may modestly alter ifosfamide metabolism.

What to do

No dose change is usually needed. Monitor for efficacy and toxicity of both drugs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ifosfamide and Tazemetostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ifosfamide with Tazemetostat?

MediHelp rates the interaction as minor. Ifosfamide and Tazemetostat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tazemetostat is a weak CYP3A4 inducer and a CYP3A4 substrate, and ifosfamide is a substrate with possible weak inhibitory effects. Any change in exposure is probably small, but ifosfamide activation could change slightly.

How serious is the interaction between Ifosfamide and Tazemetostat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed. Monitor for efficacy and toxicity of both drugs.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in